TITLE:
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

CONDITION:
Asthma, Bronchial

INTERVENTION:
MK0476, montelukast sodium

SUMMARY:

      The purpose of this study is to determine the protective effect of an approved medication on
      asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure
      to cats.
    

DETAILED DESCRIPTION:

      The duration of treatment is 2 weeks.
    

ELIGIBILITY:
Gender: All
Age: 15 Years to 55 Years
Criteria:

        Inclusion Criteria:

          -  Increased sensitivity to cat allergen proven by positive allergy testing, and by
             decreased lung function and increased symptoms of allergic rhinitis (runny nose) upon
             exposure to cats.

        Exclusion Criteria:

          -  Medical history of a lung disorder (other than asthma) or a recent upper respiratory
             tract infection.
      
